518 related articles for article (PubMed ID: 17526554)
1. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
Vonk MC; Marjanovic Z; van den Hoogen FH; Zohar S; Schattenberg AV; Fibbe WE; Larghero J; Gluckman E; Preijers FW; van Dijk AP; Bax JJ; Roblot P; van Riel PL; van Laar JM; Farge D
Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554
[TBL] [Abstract][Full Text] [Related]
2. Autologous stem cell transplantation for systemic sclerosis.
Farge D; Nash R; Laar JM
Autoimmunity; 2008 Dec; 41(8):616-24. PubMed ID: 18958754
[TBL] [Abstract][Full Text] [Related]
3. Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis.
Oyama Y; Barr WG; Statkute L; Corbridge T; Gonda EA; Jovanovic B; Testori A; Burt RK
Bone Marrow Transplant; 2007 Sep; 40(6):549-55. PubMed ID: 17646844
[TBL] [Abstract][Full Text] [Related]
4. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry.
Farge D; Passweg J; van Laar JM; Marjanovic Z; Besenthal C; Finke J; Peter HH; Breedveld FC; Fibbe WE; Black C; Denton C; Koetter I; Locatelli F; Martini A; Schattenberg AV; van den Hoogen F; van de Putte L; Lanza F; Arnold R; Bacon PA; Bingham S; Ciceri F; Didier B; Diez-Martin JL; Emery P; Feremans W; Hertenstein B; Hiepe F; Luosujärvi R; Leon Lara A; Marmont A; Martinez AM; Pascual Cascon H; Bocelli-Tyndall C; Gluckman E; Gratwohl A; Tyndall A;
Ann Rheum Dis; 2004 Aug; 63(8):974-81. PubMed ID: 15249325
[TBL] [Abstract][Full Text] [Related]
5. Optimization of autologous stem cell transplantation for systemic sclerosis -- a single-center longterm experience in 26 patients with severe organ manifestations.
Henes JC; Schmalzing M; Vogel W; Riemekasten G; Fend F; Kanz L; Koetter I
J Rheumatol; 2012 Feb; 39(2):269-75. PubMed ID: 22247352
[TBL] [Abstract][Full Text] [Related]
6. Immunological reconstitution after autologous hematopoietic stem cell transplantation in patients with systemic sclerosis: relationship between clinical benefits and intensity of immunosuppression.
Bohgaki T; Atsumi T; Bohgaki M; Furusaki A; Kondo M; Sato-Matsumura KC; Abe R; Kataoka H; Horita T; Yasuda S; Amasaki Y; Nishio M; Sawada K; Shimizu H; Koike T
J Rheumatol; 2009 Jun; 36(6):1240-8. PubMed ID: 19447934
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.
Witzens-Harig M; Heilmann C; Hensel M; Kornacker M; Benner A; Haas R; Fruehauf S; Ho AD
Stem Cells; 2007 Jan; 25(1):228-35. PubMed ID: 17204607
[TBL] [Abstract][Full Text] [Related]
9. Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma.
Tomblyn M; Burns LJ; Blazar B; Wagner J; Lee C; Rogers T; McGlave P; Miller JS; Weisdorf DJ
Bone Marrow Transplant; 2007 Jul; 40(2):111-8. PubMed ID: 17530003
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.
Fassas A; Passweg JR; Anagnostopoulos A; Kazis A; Kozak T; Havrdova E; Carreras E; Graus F; Kashyap A; Openshaw H; Schipperus M; Deconinck E; Mancardi G; Marmont A; Hansz J; Rabusin M; Zuazu Nagore FJ; Besalduch J; Dentamaro T; Fouillard L; Hertenstein B; La Nasa G; Musso M; Papineschi F; Rowe JM; Saccardi R; Steck A; Kappos L; Gratwohl A; Tyndall A; Samijn J;
J Neurol; 2002 Aug; 249(8):1088-97. PubMed ID: 12195460
[TBL] [Abstract][Full Text] [Related]
11. Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis.
Statkute L; Oyama Y; Barr WG; Sufit R; Ho S; Verda L; Loh Y; Yaung K; Quigley K; Burt RK
Ann Rheum Dis; 2008 Jul; 67(7):991-7. PubMed ID: 17947303
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival.
Dean R; Masci P; Pohlman B; Andresen S; Serafino S; Sobecks R; Kuczkowski E; Curtis J; Maciejewski J; Rybicki L; Kalaycio M; Hsi E; Theil K; Bolwell BJ
Bone Marrow Transplant; 2005 Dec; 36(12):1049-52. PubMed ID: 16247431
[TBL] [Abstract][Full Text] [Related]
13. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease.
Musso M; Porretto F; Crescimanno A; Bondi F; Polizzi V; Scalone R
Am J Hematol; 2001 Feb; 66(2):75-9. PubMed ID: 11421302
[TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy.
Verburg RJ; Kruize AA; van den Hoogen FH; Fibbe WE; Petersen EJ; Preijers F; Sont JK; Barge RM; Bijlsma JW; van de Putte LB; Breedveld FC; van Laar JM
Arthritis Rheum; 2001 Apr; 44(4):754-60. PubMed ID: 11315914
[TBL] [Abstract][Full Text] [Related]
15. Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study.
Farge D; Marolleau JP; Zohar S; Marjanovic Z; Cabane J; Mounier N; Hachulla E; Philippe P; Sibilia J; Rabian C; Chevret S; Gluckman E;
Br J Haematol; 2002 Dec; 119(3):726-39. PubMed ID: 12437652
[TBL] [Abstract][Full Text] [Related]
16. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan.
Ayano M; Tsukamoto H; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Miyamoto T; Horiuchi T; Niiro H; Nagafuji K; Harada M; Akashi K
Arthritis Res Ther; 2019 Jan; 21(1):30. PubMed ID: 30670057
[TBL] [Abstract][Full Text] [Related]
17. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease.
Cassinotti A; Annaloro C; Ardizzone S; Onida F; Della Volpe A; Clerici M; Usardi P; Greco S; Maconi G; Porro GB; Deliliers GL
Gut; 2008 Feb; 57(2):211-7. PubMed ID: 17895357
[TBL] [Abstract][Full Text] [Related]
18. Choosing appropriate patients with systemic sclerosis for treatment by autologous stem cell transplantation.
Clements PJ; Furst DE
J Rheumatol Suppl; 1997 May; 48():85-8. PubMed ID: 9150125
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients.
Traynor AE; Barr WG; Rosa RM; Rodriguez J; Oyama Y; Baker S; Brush M; Burt RK
Arthritis Rheum; 2002 Nov; 46(11):2917-23. PubMed ID: 12428232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
